Effect of lipid-lowering treatment on lipid and glycemic profile of patients with elevated lipoprotein(a) levels Amalia Despoina Koutsogianni, Fotios Barkas, Constantinos Tellis, Alexandros Tselepis, George Liamis, Evangelos Liberopoulos
Ischemic stroke in patients with atrial fibrillation – do we need to treat with statins? Matilda Florentin, George Ntaios, Haralampos Milionis
Pathogenetic mechanisms of statin dysglycemia and risk of new-onset diabetes Maria Pappa, Vasilios Tsimihodimos, Antonios Alaveras
PCSK9 inhibitors: The breakthrough lipid-lowering treatment at real-life setting – A 2-year regional lipid clinic experience Georgia Anastasiou, George Liamis, Haralampos Milionis, Moses Elisaf, Eliza Christopoulou, Theodora Dimitriou, Evangelos N. Liberopoulos
The role of lipid-lowering treatment in the secondary prevention of ischemic stroke Eirini Konstantinidou, Konstantinos Tziomalos
Low-density lipoprotein cholesterol targets: lowest is best Maria Papagianni, Achilleas Papagiannis, Konstantinos Tziomalos
2013 American College of Cardiology/American Heart Association Lipid Guidelines after the 2016 American College of Cardiology Expert Panel Consensus Statement: To err is human, to admit it, divine V. G. Athyros, G. Sfikas, C. Boutari, K. Imprialos, K. Tziomalos, A. Karagiannis
Effect of statins in endothelial progenitor cell functionality Vasileios G. Chantzichristos, Alexandros D. Tselepis
Endothelial dysfunction in heart failure: The role of statins Evangelos Oikonomou, Gerasimos Siasos, Christina Chrysohoou, Dimitris Tousoulis